1. Home
  2. USEA vs LEXX Comparison

USEA vs LEXX Comparison

Compare USEA & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Maritime Corporation

USEA

United Maritime Corporation

HOLD

Current Price

$2.06

Market Cap

17.2M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.97

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USEA
LEXX
Founded
2004
2004
Country
Greece
Canada
Employees
N/A
7
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
16.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
USEA
LEXX
Price
$2.06
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
87.0K
185.3K
Earning Date
05-21-2026
04-14-2026
Dividend Yield
11.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.55
N/A
Revenue Next Year
$4.60
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$0.46
52 Week High
$2.28
$1.67

Technical Indicators

Market Signals
Indicator
USEA
LEXX
Relative Strength Index (RSI) 49.90 65.41
Support Level $1.88 $0.80
Resistance Level $2.24 $1.05
Average True Range (ATR) 0.10 0.08
MACD -0.01 0.03
Stochastic Oscillator 32.76 75.02

Price Performance

Historical Comparison
USEA
LEXX

About USEA United Maritime Corporation

United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of five dry bulk vessels, comprising two Kamsarmax and three Panamax vessels with an aggregate cargo-carrying capacity of approximately 396,297 dwt.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: